English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

A hallmark of regulatory B cells is IL-10 production, hence their designation as IL-10 +  B cells. Little is known about the ability of self-antigens to induce IL-10 +  B cells in Graves’ disease (GD), Hashimoto’s thyroiditis (HT), or other autoimmune disease. Here we pulsed purified B cells from 12 HT patients, 12 GD patients, and 12 healthy donors with the thyroid self-antigen, thyroglobulin (TG) and added the B cells back to the remaining peripheral blood mononuclear cells (PBMCs). This procedure induced IL-10 +  B-cell differentiation in GD. A similar tendency was observed in healthy donors, but not in cells from patients with HT. In GD, B cells primed with TG induced IL-10-producing CD4 +  T cells. To assess the maximal frequency of inducible IL-10 +  B cells in the three donor groups PBMCs were stimulated with PMA/ionomycin. The resulting IL-10 +  B-cell frequency was similar in the three groups and correlated with free T 3  levels in GD patients. IL-10 +  B cells from both patient groups displayed CD25 or TIM-1 more frequently than did those from healthy donors. B-cell expression of two surface marker combinations previously associated with regulatory B-cell functions, CD24 hi CD38 hi  and CD27 + CD43 + , did not differ between patients and healthy donors. In conclusion, our findings indicate that autoimmune thyroiditis is not associated with reduced frequency of IL-10 +  B cells. These results do not rule out regulatory B-cell dysfunction, however. The observed phenotypic differences between IL-10 +  B cells from patients and healthy donors are discussed.

Characterization of Regulatory B Cells in Graves’ Disease and Hashimoto’s Thyroiditis